1. Balwierczak JL, Johnson CL, Schwartz A (1987) The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma. Mol Pharmacol 31:175?179
2. Batra S (1985) Characterization of [3H]-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry. Br J Pharmacol 85:767?774
3. Bennet JP Jr, Yamamura HI (1985) Neurotransmitter, hormone, or drug receptor binding methods. In: Yamamura HI, Enna SJ, Kuhar MJ (eds) Neurotransmitter receptor binding. Raven Press, New York, pp 61?89
4. Boer R, Grassegger A, Schudt C, Glossmann H (1989) (+)-Niguldipine binds with a very high affinity to Ca2+ channels and to a subtype of ?1-adrenoceptors. Eur J Pharmacol 172:131?145
5. Bolger GT, Gengo P, Klockowski R, Luchowski E, Siegel H, Janis A, Triggle AM, Triggle DJ (1983) Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther 225:291?309